FDA's AI Tool 'Elsa' Fails to Deliver on Promises, Creates Non-Existent Studies

Issues with FDA's AI Tool 'Elsa'

• 💡 The FDA unveiled an artificial intelligence tool named Elsa earlier this year, intended to expedite the approval of drugs and medical devices.
• ⚠️ However, three current FDA employees report that Elsa is generating studies that do not actually exist, undermining trust in its vital work.
• 🚫 Elsa also struggles to access crucial documents necessary for determining the effectiveness of devices and drugs.

Challenges in AI Implementation

• 🔬 The process involves scientific reviewers clicking on links provided by Elsa to examine studies, a step that is hindered by the tool's limitations.
• 📊 Currently, the use of AI in medical applications within the FDA has been minimal, partly due to federal oversight challenges.
• 📈 The Trump administration had previously suggested that AI could help reduce overall government spending within the health industry.